SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • May 11th, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations • California
This Separation Agreement and Release (“Agreement”) is made by and between Bittoo Kanwar (“Employee”) and Applied Molecular Transport Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
AGREEMENT FOR MODIFICATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Modification of Lease • May 11th, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations
This Agreement for Modification of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of May 2, 2023, by and between ARE-EAST JAMIE COURT, LLC, a Delaware limited liability company (“Landlord”), and APPLIED MOLECULAR TRANSPORT INC., a Delaware corporation (“Tenant”), with reference to the following:
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • May 11th, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations • California
This Separation Agreement and Release (“Agreement”) is made by and between Tahir Mahmood (“Employee”) and Applied Molecular Transport Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
THIRD AMENDMENT TO LEASELease • May 11th, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE (this “Third Amendment”) is made as of May 2, 2023, but effective as of 11:59 PM Pacific Time on March 31, 2023, by and between ARE-EAST JAMIE COURT, LLC, a Delaware limited liability company (“Landlord”), and APPLIED MOLECULAR TRANSPORT INC., a Delaware corporation (“Tenant”).
APPLIED MOLECULAR TRANSPORT INC. CONSULTING AGREEMENTConsulting Agreement • May 11th, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”) is made and entered into as of April 10, 2023 (the “Effective Date”) by and between Applied Molecular Transport Inc., a Delaware corporation having its principal place of business located at 450 East Jamie Court, South San Francisco, CA 94080 (the “Company”), and Lake Sherwood Partners, LLC, a Delaware limited liability company having a principal place of business at 2105 Ray Drive, Burlingame, CA 94010-5422 (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”).
